Working… Menu

Disulfiram for Cocaine-Alcohol Abuse - 3

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00000278
Recruitment Status : Completed
First Posted : September 21, 1999
Last Update Posted : June 18, 2020
National Institute on Drug Abuse (NIDA)
VA Connecticut Healthcare System
Information provided by (Responsible Party):
Yale University

Brief Summary:
The purpose of this study is to evaluate disulfiram for cocaine-alcohol abuse.

Condition or disease Intervention/treatment Phase
Alcohol-Related Disorders Cocaine-Related Disorders Drug: Disulfiram Phase 2

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Enrollment : 0 participants
Primary Purpose: Treatment
Official Title: Disulfiram for Cocaine-Alcohol Abuse
Study Start Date : September 1994
Actual Primary Completion Date : August 1999
Actual Study Completion Date : August 1999

Resource links provided by the National Library of Medicine

Primary Outcome Measures :
  1. Side effects
  2. Cocaine effects

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Please contact site for information.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00000278

Layout table for location information
United States, Connecticut
VA Connecticut Healthcare System
New Haven, Connecticut, United States, 06519
Sponsors and Collaborators
Yale University
National Institute on Drug Abuse (NIDA)
VA Connecticut Healthcare System
Layout table for investigator information
Principal Investigator: Thomas R Kosten, M.D. VA Connecticut Healthcare System
Biol Psy. 37: 560-563, 1995. NIDA Research Monograph, 174:138, 1997. Ther Drug Monograph, 18:460-464, 1996.

Layout table for additonal information
Responsible Party: Yale University Identifier: NCT00000278    
Other Study ID Numbers: NIDA-09250-3
P50DA009250 ( U.S. NIH Grant/Contract )
First Posted: September 21, 1999    Key Record Dates
Last Update Posted: June 18, 2020
Last Verified: June 2020
Keywords provided by Yale University:
Cocaine-Related Disorders
Additional relevant MeSH terms:
Layout table for MeSH terms
Cocaine-Related Disorders
Alcohol-Related Disorders
Pathologic Processes
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders
Alcohol Deterrents
Acetaldehyde Dehydrogenase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action